5 Insurance Stocks to Buy for a Decade of Rising Dividends

The article highlights Aflac, Chubb, Cincinnati Financial, Old Republic and Travelers as potential long-term dividend-growth stocks, citing dividend-growth streaks of 22 to 66 years and generally manageable payout ratios. Travelers reported Q3 2026 EPS of $9.18 versus $7.39 expected, while Old Republic’s Q3 net income fell nearly 13% year over year to $243.2 million. Risks include Aflac’s slower premium growth in Japan, underwriting pressure at Chubb and Cincinnati, housing weakness affecting Old Republic’s title business, and Travelers’ reliance on investment gains.

Analysis

The durable edge in these names is underwriting discipline and float duration—not the dividend streak itself. Higher reinvestment yields can support investment income over time, but a rate reversal eventually lowers new-money yields; meanwhile, catastrophe losses, claims inflation, or reserve deterioration can overwhelm incremental portfolio income. The timing is asymmetric: investment income compounds over quarters, while a severe cat season or equity drawdown can hit reported results immediately.

For the next 1–3 months, favor underwriting evidence over headline EPS. CB and TRV look better positioned if pricing and loss discipline hold; however, recent strength raises the bar for results, and TRV’s earnings beat should not be extrapolated if it was investment-driven. CINF adds a distinct risk: its equity-heavy portfolio can transmit a market selloff into investment results at the same time underwriting is under pressure. ORI’s title exposure is more directly tied to housing transaction activity; its core dividend appears more insulated than special distributions. AFL’s Japan premium trend merits monitoring before treating its historical repurchases and dividend growth as a forward run rate.

Over 6–18 months, the key divergence is likely to be underwriting margin and portfolio mix, not dividend history. A basket reduces single-event exposure but remains exposed to common catastrophe, claims-cost, and interest-rate factors. The contrarian point: a long dividend record is not a valuation floor, and recent investment gains may mask weaker underlying insurance economics. Berkshire’s position in CB is a potential flow catalyst, but a stake change alone would not establish a change in CB’s fundamentals.

Key Decisions for Investors

• Prefer a modest relative-quality tilt to CB and TRV over CINF, rather than buying all five equally on dividend history alone. Reassess after quarterly combined ratios and underlying investment income; the thesis weakens if underwriting deteriorates or investment income is doing most of the earnings work.
• Treat CINF as the portfolio’s higher equity-beta insurer: avoid adding ahead of a broad equity drawdown unless underwriting turns. Monitor equity-market exposure alongside combined ratio and reserve development; a sustained combined ratio above 100% would challenge the quality premium.
• For ORI, separate the recurring core dividend from special payouts. Consider exposure only if housing transaction activity stabilizes and title premiums translate into earnings; weaker housing turnover or a core payout increase unsupported by earnings would falsify the recovery case.
• Keep AFL on watch rather than extrapolating past buybacks or dividend growth. A stabilization in Japanese premiums would support the case; continued weakness alongside slower capital returns would argue against treating its dividend-growth history as a current growth forecast.